Medtronic (NY:MDT)

88.48 +0.73 (+0.83%)

Official Closing Price Updated: 7:00 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9

...

68 69 Next >

Medtronic Hits Ten-Quarter Growth Peak in Q3 Fiscal 2026, Signaling Resurgence in MedTech Sector

February 19, 2026

Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for its fiscal third quarter of 2026, marking a significant turning point for the medical technology giant. The...

Via MarketMinute

Danaher’s $9.9 Billion Acquisition of Masimo: A Strategic Pivot to the Future of Patient Monitoring

February 19, 2026

In a move that has sent shockwaves through the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to acquire...

Via MarketMinute

Topics Artificial Intelligence Economy

Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues

February 18, 2026

Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings...

Via MarketMinute

Topics Earnings

Medtronic (NYSE:MDT) Beats Q3 Earnings Estimates but Stock Dips in Premarket ↗

February 17, 2026

Via Chartmill

Medtronic Analysts Cut Their Forecasts After Q3 Earnings ↗

February 18, 2026

Via Benzinga

S&P 500 Edges Higher: Investor Fear Eases Slightly, Greed Index Remains In 'Fear' Zone ↗

February 18, 2026

Medtronic and Orion post earnings, while investors await results from Analog Devices, Global Payments, and DoorDash.

Via Benzinga

Topics Stocks

Medtronic’s “Textbook” Reversal: How High Can It Really Go in 2026? ↗

February 17, 2026

Via MarketBeat

Danaher's $9.9 Billion Bet: Masimo Acquisition to Redefine the Diagnostics Landscape

February 17, 2026

In a move that signals a massive consolidation in the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to...

Via MarketMinute

Topics Artificial Intelligence Economy

Medtronic PLC (NYSE:MDT): A Durable Dividend Stock for Income Investors ↗

February 16, 2026

Via Chartmill

Medtronic Reaffirms 2026 Outlook As Heart and Diabetes Units Drive Growth ↗

February 17, 2026

Medtronic beats Q3 sales and earnings estimates, driven by heart and diabetes growth, while reaffirming 2026 outlook.

Via Benzinga

Gold Down 3%; Medtronic Earnings Top Views ↗

February 17, 2026

Via Benzinga

Medtronic (MDT) Q3 2026 Earnings Call Transcript ↗

February 17, 2026

Medtronic (MDT) Q3 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings World Trade

Medtronic (MDT): The Sleeping Giant Awakes with Strong Q3 FY26 Momentum

February 17, 2026

Today’s Date: February 17, 2026 Introduction Medtronic plc (NYSE: MDT) has long been the sleeping giant of the medical technology sector. For years, the Dublin-domiciled powerhouse was viewed by Wall...

Via Finterra

Topics Artificial Intelligence Earnings Economy

Medtronic, Genuine Parts And 3 Stocks To Watch Heading Into Tuesday ↗

February 17, 2026

US stock futures lower. Medtronic, Genuine Parts, Sonoco, Fluor, and Toll Brothers expected to report earnings today.

Via Benzinga

Baxter International (BAX) Deep Dive: Navigating the 16% Plunge and a New Strategic Era

February 16, 2026

On February 16, 2026, the mood surrounding Baxter International (NYSE: BAX) is one of cautious sobriety following a seismic shift in investor confidence. Long regarded as a defensive staple of the...

Via Finterra

Topics Artificial Intelligence Earnings Economy

Uncovering Potential: Medtronic's Earnings Preview ↗

February 16, 2026

Via Benzinga

3 Dividend Stocks to Double Up On Right Now ↗

February 16, 2026

Dividend-paying stocks tend to greatly outperform non-payers. Here are three promising dividend payers.

Via The Motley Fool

Topics Artificial Intelligence Economy

Option Volatility And Earnings Report For February 16 - 20

February 16, 2026

Earnings season is starting to slow down now, which may come as a welcome relief for some. However, we do still have some important companies due to report with Walmart, Alibaba, Newmont Mining,...

Via Barchart.com

Stock Market Today, Feb. 13: Inflation Data Steadies Market and Slows AI Disruption Losses ↗

February 13, 2026

Positive earnings pushed Applied Materials and Rivian Automotive higher as better-than-expected inflation data helped steady markets today, Feb. 13, 2026.

Via The Motley Fool

Topics Artificial Intelligence Earnings Economy

Medtronic Wins FDA Nod For Spine Surgery Tech Designed To Cut Repeat Imaging ↗

February 13, 2026

Medtronic's Stealth AXiS spine surgery system wins FDA clearance, offering real-time alignment tracking and broader surgical flexibility.

Via Benzinga

Peering Into Medtronic PLC's Recent Short Interest ↗

February 12, 2026

Via Benzinga

Pure-Play Pivot: A Deep Dive into Becton Dickinson (BDX) Following the Waters Spin-Off and 2026 Guidance Reset

February 11, 2026

Becton, Dickinson and Company (NYSE: BDX), widely known as BD, has long been a cornerstone of the global healthcare infrastructure. However, as of February 11, 2026, the company is making headlines not...

Via Finterra

Topics Artificial Intelligence Economy Intellectual Property

Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days

February 10, 2026

Via AB Newswire

Intuitive Surgical’s New Heart: Analyzing the da Vinci 5 Cardiac Clearance and the Future of Robotic Surgery

February 09, 2026

As of February 9, 2026, the medtech landscape is witnessing a pivotal shift centered around the long-awaited return of robotics to the heart of the operating room. Intuitive Surgical, Inc. (NASDAQ:...

Via Finterra

Topics Artificial Intelligence Economy World Trade

Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination

February 09, 2026

Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5...

Via Finterra

Topics Artificial Intelligence Economy Product Recall

What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill. ↗

February 08, 2026

These companies pay very healthy dividends.

Via The Motley Fool

Topics Bonds

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

February 07, 2026

Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider.

Via The Motley Fool

The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition

February 05, 2026

In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for...

Via MarketMinute

Topics Supply Chain

Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)

February 05, 2026

February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left...

Via Finterra

Topics Product Recall World Trade

Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors ↗

February 04, 2026

Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.

Via The Motley Fool

Topics Earnings Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.